2.4.0.8 Html 322 280 1 true 71 0 false 5 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.chelseatherapeutics.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.chelseatherapeutics.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY false false R6.htm 106 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityParenthetical CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] false false R7.htm 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/ConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] false false R9.htm 109 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPolicies The Company, Basis of Presentation and Summary of Significant Accounting Policies false false R10.htm 110 - Disclosure - Short-term Investments Sheet http://www.chelseatherapeutics.com/role/ShorttermInvestments Short-term Investments false false R11.htm 111 - Disclosure - Fair Value Measurements Sheet http://www.chelseatherapeutics.com/role/FairValueMeasurements Fair Value Measurements false false R12.htm 112 - Disclosure - Property and equipment Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipment Property and equipment false false R13.htm 113 - Disclosure - Common Stock Offerings Sheet http://www.chelseatherapeutics.com/role/CommonStockOfferings Common Stock Offerings false false R14.htm 114 - Disclosure - Commitments Sheet http://www.chelseatherapeutics.com/role/Commitments Commitments false false R15.htm 115 - Disclosure - Stockholders' Equity Sheet http://www.chelseatherapeutics.com/role/StockholdersEquity Stockholders' Equity false false R16.htm 116 - Disclosure - Income Taxes Sheet http://www.chelseatherapeutics.com/role/IncomeTaxes Income Taxes false false R17.htm 118 - Disclosure - Savings and Retirement Plan Sheet http://www.chelseatherapeutics.com/role/SavingsAndRetirementPlan Savings and Retirement Plan false false R18.htm 119 - Disclosure - Restructuring Sheet http://www.chelseatherapeutics.com/role/Restructuring Restructuring false false R19.htm 120 - Disclosure - Subsequent Events Sheet http://www.chelseatherapeutics.com/role/SubsequentEvents Subsequent Events false false R20.htm 121 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies The Company, Basis of Presentation and Summary of Significant Accounting Policies (Policies) false false R21.htm 122 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables The Company, Basis of Presentation and Summary of Significant Accounting Policies (Tables) false false R22.htm 123 - Disclosure - Property and equipment (Tables) Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipmentTables Property and equipment (Tables) false false R23.htm 124 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R24.htm 125 - Disclosure - Income Taxes (Tables) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesTables Income Taxes (Tables) false false R25.htm 126 - Disclosure - Restructuring (Tables) Sheet http://www.chelseatherapeutics.com/role/RestructuringTables Restructuring (Tables) false false R26.htm 127 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details) false false R27.htm 128 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 1) Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1 The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 1) false false R28.htm 129 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 2) Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails2 The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details 2) false false R29.htm 130 - Disclosure - The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.chelseatherapeutics.com/role/CompanyBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsTextual The Company, Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) false false R30.htm 131 - Disclosure - Short-term Investments (Details Textual) Sheet http://www.chelseatherapeutics.com/role/ShorttermInvestmentsDetailsTextual Short-term Investments (Details Textual) false false R31.htm 132 - Disclosure - Fair Value Measurements (Details Textual) Sheet http://www.chelseatherapeutics.com/role/FairValueMeasurementsDetailsTextual Fair Value Measurements (Details Textual) false false R32.htm 133 - Disclosure - Property and equipment (Details) Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipmentDetails Property and equipment (Details) false false R33.htm 134 - Disclosure - Property and equipment (Details Textual) Sheet http://www.chelseatherapeutics.com/role/PropertyAndEquipmentDetailsTextual Property and equipment (Details Textual) false false R34.htm 135 - Disclosure - Common Stock Offerings (Details Textual) Sheet http://www.chelseatherapeutics.com/role/CommonStockOfferingsDetailsTextual Common Stock Offerings (Details Textual) false false R35.htm 136 - Disclosure - Commitments (Details Textual) Sheet http://www.chelseatherapeutics.com/role/CommitmentsDetailsTextual Commitments (Details Textual) false false R36.htm 137 - Disclosure - Stockholders' Equity (Details) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R37.htm 138 - Disclosure - Stockholders' Equity (Details 1) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) false false R38.htm 139 - Disclosure - Stockholders' Equity (Details 2) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails2 Stockholders' Equity (Details 2) false false R39.htm 141 - Disclosure - Stockholders' Equity (Details 3) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetails3 Stockholders' Equity (Details 3) false false R40.htm 142 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.chelseatherapeutics.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) false false R41.htm 143 - Disclosure - Income Taxes (Details) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesDetails Income Taxes (Details) false false R42.htm 144 - Disclosure - Income Taxes (Details 1) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) false false R43.htm 145 - Disclosure - Income Taxes (Details Textual) Sheet http://www.chelseatherapeutics.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) false false R44.htm 146 - Disclosure - Savings and Retirement Plan (Details Textual) Sheet http://www.chelseatherapeutics.com/role/SavingsAndRetirementPlanDetailsTextual Savings and Retirement Plan (Details Textual) false false R45.htm 147 - Disclosure - Restructuring (Details) Sheet http://www.chelseatherapeutics.com/role/RestructuringDetails Restructuring (Details) false false R46.htm 148 - Disclosure - Restructuring (Details Textual) Sheet http://www.chelseatherapeutics.com/role/RestructuringDetailsTextual Restructuring (Details Textual) false false R47.htm 149 - Disclosure - Subsequent Events (Details Textual) Sheet http://www.chelseatherapeutics.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) false false All Reports Book All Reports Element chtp_EstimatedForfeitureRate had a mix of decimals attribute values: 2 3. Element chtp_PotentialFutureMilestonePayments had a mix of decimals attribute values: -5 0. Element us-gaap_CommonStockParOrStatedValuePerShare had a mix of decimals attribute values: 2 4. Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 4. Element us-gaap_ResearchAndDevelopmentExpense had a mix of decimals attribute values: -5 0. Element us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost had a mix of decimals attribute values: -5 0. 'Monetary' elements on report '135 - Disclosure - Common Stock Offerings (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '145 - Disclosure - Income Taxes (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Dec. 31, 2007' Process Flow-Through: Removing column 'Dec. 31, 2006' Process Flow-Through: Removing column 'Dec. 31, 2005' Process Flow-Through: Removing column 'Dec. 31, 2004' Process Flow-Through: Removing column 'Apr. 02, 2002' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Mar. 31, 2010' Process Flow-Through: Removing column 'Mar. 31, 2007' Process Flow-Through: Removing column 'Dec. 31, 2006' Process Flow-Through: Removing column 'Feb. 28, 2006' Process Flow-Through: Removing column 'Dec. 31, 2004' Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2006' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2005' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2004' Process Flow-Through: 106 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Parenthetical] Process Flow-Through: 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] Process Flow-Through: Removing column '1 Months Ended Jan. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '141 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011 Common Stock [Member]' chtp-20131231.xml chtp-20131231.xsd chtp-20131231_cal.xml chtp-20131231_def.xml chtp-20131231_lab.xml chtp-20131231_pre.xml true true